{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T04:41:09Z","timestamp":1650861669134},"reference-count":8,"publisher":"AACN Publishing","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12,1]]},"abstract":"<jats:p>Drugs that work on the hematologic system play an important role in helping to limit the morbidity and mortality that can be associated with an acute coronary syndrome. The pharmacology of the fibrinolytic agents, thrombin inhibitors, and antiplatelet agents is described. A case study of a woman having an ST-segment elevation myocardial infarction is reviewed to highlight the importance of drugs that work on the hematologic system.<\/jats:p>","DOI":"10.4037\/ccn2012104","type":"journal-article","created":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T08:45:32Z","timestamp":1354351532000},"page":"35-41","source":"Crossref","is-referenced-by-count":0,"title":["Clots Kill: Hematologic Pharmacology for ST-Segment Elevation Myocardial Infarction"],"prefix":"10.4037","volume":"32","author":[{"given":"Stacy H.","family":"James","sequence":"first","affiliation":[{"name":"Stacy H. James is a cardiology acute care nurse practitioner at Queen of the Valley Medical Center in Napa, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2471","reference":[{"key":"2022042504091411900_b1-0320035","first-page":"e59","article-title":"Heart disease and stroke statistics 2009 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"2022042504091411900_b2-0320035","first-page":"256","article-title":"Anticoagulant, antiplatelet, and fibrinolytic (thrombolytic) drugs","volume-title":"Modern pharmacology with clinical applications","author":"Fedan","year":"2004","edition":"6th ed"},{"key":"2022042504091411900_b3-0320035","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jacc.2009.10.015","article-title":"2009 Focused updates: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction and ACC\/AHA\/SCAI guidelines on percutaneous coronary intervention","volume":"54","author":"Kushner","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2022042504091411900_b4-0320035","first-page":"283","article-title":"Principles of antithrombotic therapy","volume-title":"Williams hematology","author":"Francis","year":"2006","edition":"7th ed"},{"key":"2022042504091411900_b5-0320035","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jacc.2007.01.093","article-title":"Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial","volume":"49","author":"Gibson","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2022042504091411900_b6-0320035","doi-asserted-by":"crossref","first-page":"199S","DOI":"10.1378\/chest.08-0672","article-title":"Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Patrono","year":"2008","journal-title":"Chest"},{"issue":"2","key":"2022042504091411900_b7-0320035","first-page":"166","article-title":"Death by clot: acute coronary syndrome, ischemic stroke, pulmonary embolism, and disseminated intravascular coagulation","volume":"20","author":"Dressler","year":"2009","journal-title":"AACN Adv Crit Care"},{"key":"2022042504091411900_b8-0320035","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Critical Care Nurse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacnjournals.org\/ccnonline\/article-pdf\/32\/6\/35\/121524\/35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacnjournals.org\/ccnonline\/article-pdf\/32\/6\/35\/121524\/35.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T04:09:27Z","timestamp":1650859767000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/ccnonline\/article\/32\/6\/35\/3269\/Clots-Kill-Hematologic-Pharmacology-for-ST-Segment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,1]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12,1]]}},"URL":"https:\/\/doi.org\/10.4037\/ccn2012104","relation":{},"ISSN":["0279-5442","1940-8250"],"issn-type":[{"value":"0279-5442","type":"print"},{"value":"1940-8250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,1]]}}}